The DOI matches its Crossref record; 176 of the 176 references it cites were found in a registry or an index.
Familial Isolated Pituitary Adenomas (FIPA) and the Pituitary Adenoma Predisposition due to Mutations in the Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene
Open accessAbstract
Pituitary adenomas are one of the most frequent intracranial tumors and occur with a prevalence of approximately 1:1000 in the developed world. Pituitary adenomas have a serious disease burden, and their management involves neurosurgery, biological therapies, and radiotherapy. Early diagnosis of pituitary tumors while they are smaller may help increase cure rates. Few genetic predictors of pituitary adenoma development exist. Recent years have seen two separate, complimentary advances in inherited pituitary tumor research. The clinical condition of familial isolated pituitary adenomas (FIPA) has been described, which encompasses the familial occurrence of isolated pituitary adenomas outside of the setting of syndromic conditions like multiple endocrine neoplasia type 1 and Carney complex. FIPA families comprise approximately 2% of pituitary adenomas and represent a clinical entity with homogeneous or heterogeneous pituitary adenoma types occurring within the same kindred. The aryl hydrocarbon receptor interacting protein (AIP) gene has been identified as causing a pituitary adenoma predisposition of variable penetrance that accounts for 20% of FIPA families. Germline AIP mutations have been shown to associate with the occurrence of large pituitary adenomas that occur at a young age, predominantly in children/adolescents and young adults. AIP mutations are usually associated with somatotropinomas, but prolactinomas, nonfunctioning pituitary adenomas, Cushing disease, and other infrequent clinical adenoma types can also occur. Gigantism is a particular feature of AIP mutations and occurs in more than one third of affected somatotropinoma patients. Study of pituitary adenoma patients with AIP mutations has demonstrated that these cases raise clinical challenges to successful treatment. Extensive research on the biology of AIP and new advances in mouse Aip knockout models demonstrate multiple pathways by which AIP may contribute to tumorigenesis. This review assesses the current clinical and therapeutic characteristics of more than 200 FIPA families and addresses research findings among AIP mutation-bearing patients in different populations with pituitary adenomas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Initial sequencing and comparative analysis of the mouse genome
Mouse Genome Sequencing Consortium (2002) · Nature · doi:10.1038/nature01262 · Cited by 7,187
Positional Cloning of the Gene for Multiple Endocrine Neoplasia-Type 1
Chandrasekharappa, S. C., Guru, S. C., Manickam, P., Olufemi, S.-E., Collins, F. S., Emmert-Buck, M. R., Debelenko, L. V., Zhuang, Z., Lubensky, I. A., Liotta, L. A., et al. (1997) · Science · doi:10.1126/science.276.5311.404 · Cited by 2,082
CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2
Brandi, M. L. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5658 · Cited by 2,031
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
Mulligan, L. M., Kwok, J. B. J., Healey, C. S., Elsdon, M. J., Eng, C., Gardner, E., Love, D. R., Mole, S. E., Moore, J. K., Papi, L., et al. (1993) · Nature · doi:10.1038/363458a0 · Cited by 1,966
Diagnosis and treatment of hyperprolactinemia: an Endocrine Society Clinical Practice Guideline
Melmed, S., Casanueva, F. F., Hoffman, A. R., Kleinberg, D. L., Montori, V. M., Schlechte, J. A., & Wass, J. A. H. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1692 · Cited by 1,844
Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use
Bender, A. T., & Beavo, J. A. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.5 · Cited by 1,781
Activating Mutations of the Stimulatory G Protein in the McCune–Albright Syndrome
Weinstein, L. S., Shenker, A., Gejman, P. V., Merino, M. J., Friedman, E., & Spiegel, A. M. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112123252403 · Cited by 1,691
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Landis, C. A., Masters, S. B., Spada, A., Pace, A. M., Bourne, H. R., & Vallar, L. (1989) · Nature · doi:10.1038/340692a0 · Cited by 1,441
The prevalence of pituitary adenomas: A systematic review
Ezzat, S., Asa, S. L., Couldwell, W. T., Barr, C. E., Dodge, W. E., Vance, M. L., & McCutcheon, I. E. (2004) · Cancer · doi:10.1002/cncr.20412 · Cited by 1,345
The tetratricopeptide repeat: a structural motif mediating protein-protein interactions
Blatch, G. L., & Lässle, M. (1999) · BioEssays · doi:10.1002/(sici)1521-1878(199911)21:11<932::aid-bies5>3.0.co;2-n · Cited by 1,211
Fernandez, A., Karavitaki, N., & Wass, J. A. H. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03667.x · Cited by 1,115
The Complex of Myxomas, Spotty Pigmentation, and Endocrine Overactivity
CARNEY, J. A., GORDON, H., CARPENTER, P. C., SHENOY, B. V., & W. GO, V. L. (1985) · Medicine · doi:10.1097/00005792-198507000-00007 · Cited by 1,114
High Prevalence of Pituitary Adenomas: A Cross-Sectional Study in the Province of Liège, Belgium
Daly, A. F., Rixhon, M., Adam, C., Dempegioti, A., Tichomirowa, M. A., & Beckers, A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1668 · Cited by 1,025
Self-citationGenetic aspects of adenomatosis of endocrine glands
Wermer, P. (1954) · The American Journal of Medicine · doi:10.1016/0002-9343(54)90353-8 · Cited by 860
The role of hypoxia-inducible factors in tumorigenesis
Rankin, E. B., & Giaccia, A. J. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.21 · Cited by 806
Reyes, H., Reisz-Porszasz, S., & Hankinson, O. (1992) · Science · doi:10.1126/science.256.5060.1193 · Cited by 777
Guidelines for Acromegaly Management: An Update
Melmed, S., Colao, A., Barkan, A., Molitch, M., Grossman, A. B., Kleinberg, D., Clemmons, D., Chanson, P., Laws, E., Schlechte, J., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2421 · Cited by 764
Romeo, G., Ronchetto, P., Luo, Y., Barone, V., Seri, M., Ceccherini, I., Pasini, B., Bocciardi, R., Lerone, M., Kääriäinen, H., et al. (1994) · Nature · doi:10.1038/367377a0 · Cited by 700
Acromegaly pathogenesis and treatment
Melmed, S. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39375 · Cited by 687
Germ-line mutations in p27 Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans
Pellegata, N. S., Quintanilla-Martinez, L., Siggelkow, H., Samson, E., Bink, K., Höfler, H., Fend, F., Graw, J., & Atkinson, M. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603877103 · Cited by 644
Pituitary Adenoma Predisposition Caused by Germline Mutations in the AIP Gene
Vierimaa, O., Georgitsi, M., Lehtonen, R., Vahteristo, P., Kokko, A., Raitila, A., Tuppurainen, K., Ebeling, T. M. L., Salmela, P. I., Paschke, R., et al. (2006) · Science · doi:10.1126/science.1126100 · Cited by 618
Self-citationLemmens, I. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.7.1177 · Cited by 611
Schwindinger, W. F., Francomano, C. A., & Levine, M. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.11.5152 · Cited by 502
The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical ‘cure’
Nomikos, P., Buchfelder, M., & Fahlbusch, R. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01863 · Cited by 500
Pituitary Disease in MEN Type 1 (MEN1): Data from the France-Belgium MEN1 Multicenter Study
Vergès, B., Boureille, F., Goudet, P., Murat, A., Beckers, A., Sassolas, G., Cougard, P., Chambe, B., Montvernay, C., & Calender, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8145 · Cited by 483
Self-citationRET tyrosine kinase signaling in development and cancer
Arighi, E., Borrello, M. G., & Sariola, H. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.05.010 · Cited by 468
Pathogenesis of pituitary tumors
Melmed, S. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.40 · Cited by 466
The TPR snap helix: a novel protein repeat motif from mitosis to transcription
Goebl, M., & Yanagida, M. (1991) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(91)90070-c · Cited by 457
Bertherat, J., Horvath, A., Groussin, L., Grabar, S., Boikos, S., Cazabat, L., Libe, R., René-Corail, F., Stergiopoulos, S., Bourdeau, I., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2333 · Cited by 449
Ma, Q., & Whitlock, J. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.14.8878 · Cited by 417
Carver, L. A., & Bradfield, C. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.17.11452 · Cited by 416
Development of neuroendocrine lineages requires the bHLH–PAS transcription factor SIM1
Michaud, J. L., Rosenquist, T., May, N. R., & Fan, C.-M. (1998) · Genes & Development · doi:10.1101/gad.12.20.3264 · Cited by 392
Meyer, B. K., Pray-Grant, M. G., Vanden Heuvel, J. P., & Perdew, G. H. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.978 · Cited by 386
Daly, A. F., Tichomirowa, M. A., Petrossians, P., Heliövaara, E., Jaffrain-Rea, M.-L., Barlier, A., Naves, L. A., Ebeling, T., Karhu, A., Raappana, A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2556 · Cited by 384
Self-citationKolluri, S. K., Weiss, C., Koff, A., & Gottlicher, M. (1999) · Genes & Development · doi:10.1101/gad.13.13.1742 · Cited by 364
Jiang, L. I., Collins, J., Davis, R., Lin, K.-M., DeCamp, D., Roach, T., Hsueh, R., Rebres, R. A., Ross, E. M., Taussig, R., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609695200 · Cited by 358
Dominant Inheritance of the Complex of Myxomas, Spotty Pigmentation, and Endocrine Overactivity
CARNEY, J. A., HRUSKA, L. S., BEAUCHAMP, G. D., & GORDON, H. (1986) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)61843-6 · Cited by 356
Daly, A. F., Vanbellinghen, J.-F., Khoo, S. K., Jaffrain-Rea, M.-L., Naves, L. A., Guitelman, M. A., Murat, A., Emy, P., Gimenez-Roqueplo, A.-P., Tamburrano, G., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2513 · Cited by 326
Self-citationMichaud, J. L. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.14.1465 · Cited by 326
Agarwal, S. K., Mateo, C. M., & Marx, S. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2083 · Cited by 318
Kazlauskas, A., Poellinger, L., & Pongratz, I. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13519 · Cited by 302
Leontiou, C. A., Gueorguiev, M., van der Spuy, J., Quinton, R., Lolli, F., Hassan, S., Chahal, H. S., Igreja, S. C., Jordan, S., Rowe, J., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2611 · Cited by 299
The role of chaperone proteins in the aryl hydrocarbon receptor core complex
Petrulis, J. R., & Perdew, G. H. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00064-9 · Cited by 295
Germline CDKN1B/p27Kip1 Mutation in Multiple Endocrine Neoplasia
Georgitsi, M., Raitila, A., Karhu, A., van der Luijt, R. B., Aalfs, C. M., Sane, T., Vierimaa, O., Mäkinen, M. J., Tuppurainen, K., Paschke, R., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2843 · Cited by 283
Self-citationAmerican Notes for General Circulation
Dickens, C. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511703157 · Cited by 280
Ma, Q., & Whitlock, J. P. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.2144 · Cited by 273
Hirose, K., Morita, M., Ema, M., Mimura, J., Hamada, H., Fujii, H., Saijo, Y., Gotoh, O., Sogawa, K., & Fujii-Kuriyama, Y. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1706 · Cited by 270
A Nationwide Survey of Mortality in Acromegaly
Kauppinen-Mäkelin, R., Sane, T., Reunanen, A., Välimäki, M. J., Niskanen, L., Markkanen, H., Löyttyniemi, E., Ebeling, T., Jaatinen, P., Laine, H., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1381 · Cited by 269
The Pathogenesis of Pituitary Tumors
Asa, S. L., & Ezzat, S. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092259 · Cited by 263
EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas
Fukuoka, H., Cooper, O., Ben-Shlomo, A., Mamelak, A., Ren, S.-G., Bruyette, D., & Melmed, S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci60417 · Cited by 254
Mutations of the MEN1 tumor suppressor gene in pituitary tumors.
Zhuang, Z., Ezzat, S., Vortmeyer, A. O., Weil, R. J., Oldfield, E. H., Park, W. S., Pack, S., Huang, S. C., Agarwal, S. K., Guru, S. C., et al. (1997) · PubMed · Cited by 246
Meyer, B. K., & Perdew, G. H. (1999) · Biochemistry · doi:10.1021/bi982223w · Cited by 232
DAMERT, A., IKEDA, E., & RISAU, W. (1997) · Biochemical Journal · doi:10.1042/bj3270419 · Cited by 216
Theodoropoulou, M., Zhang, J., Laupheimer, S., Paez-Pereda, M., Erneux, C., Florio, T., Pagotto, U., & Stalla, G. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1189 · Cited by 216
Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island.
Simpson, D. J. W., Hibberts, N. A., McNicol, A. M., Clayton, R. N., & Farrell, W. E. (2000) · PubMed · Cited by 214
Identification of a Novel Genetic Locus for Familial Cardiac Myxomas and Carney Complex
Casey, M., Mah, C., Merliss, A. D., Kirschner, L. S., Taymans, S. E., Denio, A. E., Korf, B., Irvine, A. D., Hughes, A., Carney, J. A., et al. (1998) · Circulation · doi:10.1161/01.cir.98.23.2560 · Cited by 213
CUSHING, H. (1912) · The American Journal of the Medical Sciences · doi:10.1097/00000441-191212000-00019 · Cited by 212
Stratakis, C., Tichomirowa, M., Boikos, S., Azevedo, M., Lodish, M., Martari, M., Verma, S., Daly, A., Raygada, M., Keil, M., et al. (2010) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01406.x · Cited by 210
Self-citationCharacterization of the Ah Receptor-associated Protein, ARA9
Carver, L. A., LaPres, J. J., Jain, S., Dunham, E. E., & Bradfield, C. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.50.33580 · Cited by 208
The hsp90 Chaperone Complex Regulates Intracellular Localization of the Dioxin Receptor
Kazlauskas, A., Sundström, S., Poellinger, L., & Pongratz, I. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.7.2594-2607.2001 · Cited by 204
Enzymes that catalyse the restructuring of proteins
Schiene, C., & Fischer, G. (2000) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(99)00046-9 · Cited by 188
Cazabat, L., Bouligand, J., Salenave, S., Bernier, M., Gaillard, S., Parker, F., Young, J., Guiochon-Mantel, A., & Chanson, P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2291 · Cited by 185
Aryl hydrocarbon receptor activation by cAMP vs. dioxin: Divergent signaling pathways
Oesch-Bartlomowicz, B., Huelster, A., Wiss, O., Antoniou-Lipfert, P., Dietrich, C., Arand, M., Weiss, C., Bockamp, E., & Oesch, F. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503488102 · Cited by 185
Functional role of estrogen in pituitary tumor pathogenesis
Heaney, A. P., Fernando, M., & Melmed, S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14264 · Cited by 181
Igreja, S., Chahal, H. S., King, P., Bolger, G. B., Srirangalingam, U., Guasti, L., Chapple, J. P., Trivellin, G., Gueorguiev, M., Guegan, K., et al. (2010) · Human Mutation · doi:10.1002/humu.21292 · Cited by 180
Ah receptor signals cross-talk with multiple developmental pathways
Puga, A., Tomlinson, C. R., & Xia, Y. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.06.043 · Cited by 178
Kazlauskas, A., Poellinger, L., & Pongratz, I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007765200 · Cited by 178
The Aryl Hydrocarbon Receptor sans Xenobiotics: Endogenous Function in Genetic Model Systems
McMillan, B. J., & Bradfield, C. A. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.037259 · Cited by 177
The Aryl Hydrocarbon Receptor Functions as a Tumor Suppressor of Liver Carcinogenesis
Fan, Y., Boivin, G. P., Knudsen, E. S., Nebert, D. W., Xia, Y., & Puga, A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3090 · Cited by 177
Safe, S., Wormke, M., & Samudio, I. (2000) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1009550912337 · Cited by 175
Tichomirowa, M. A., Barlier, A., Daly, A. F., Jaffrain-Rea, M.-L., Ronchi, C., Yaneva, M., Urban, J. D., Petrossians, P., Elenkova, A., Tabarin, A., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0304 · Cited by 175
Self-citationARNT2 acts as the dimerization partner of SIM1 for the development of the hypothalamus
Michaud, J. L., DeRossi, C., May, N. R., Holdener, B. C., & Fan, C.-M. (2000) · Mechanisms of Development · doi:10.1016/s0925-4773(99)00328-7 · Cited by 173
Lahvis, G. P., Pyzalski, R. W., Glover, E., Pitot, H. C., McElwee, M. K., & Bradfield, C. A. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.008888 · Cited by 168
Bolger, G. B., Peden, A. H., Steele, M. R., MacKenzie, C., McEwan, D. G., Wallace, D. A., Huston, E., Baillie, G. S., & Houslay, M. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303269200 · Cited by 168
Keith, B., Adelman, D. M., & Simon, M. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121494298 · Cited by 166
Xekouki, P., Pacak, K., Almeida, M., Wassif, C. A., Rustin, P., Nesterova, M., de la Luz Sierra, M., Matro, J., Ball, E., Azevedo, M., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1179 · Cited by 164
AIP Mutation in Pituitary Adenomas in the 18th Century and Today
Chahal, H. S., Stals, K., Unterländer, M., Balding, D. J., Thomas, M. G., Kumar, A. V., Besser, G. M., Atkinson, A. B., Morrison, P. J., Howlett, T. A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008020 · Cited by 163
Altered Cell Cycle Control at the G2/M Phases in Aryl Hydrocarbon Receptor-Null Embryo Fibroblast
Elizondo, G., Fernandez-Salguero, P., Sheikh, M. S., Kim, G.-Y., Fornace, A. J., Lee, K. S., & Gonzalez, F. J. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26518-4 · Cited by 161
Teh, B. T., Kytölä, S., Farnebo, F., Bergman, L., Wong, F. K., Weber, G., Hayward, N., Larsson, C., Skogseid, B., Beckers, A., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.8.5059 · Cited by 160
Self-citationAhR and ARNT modulate ER signaling
Swedenborg, E., & Pongratz, I. (2009) · Toxicology · doi:10.1016/j.tox.2009.09.007 · Cited by 153
Jaffrain‐Rea, M., Angelini, M., Gargano, D., Tichomirowa, M. A., Daly, A., Vanbellinghen, J.-F., D'Innocenzo, E., Barlier, A., Giangaspero, F., Esposito, V., et al. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0094 · Cited by 153
Self-citationBrunnberg, S., Pettersson, K., Rydin, E., Matthews, J. B., Hanberg, A., & Pongratz, I. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1136688100 · Cited by 148
Association of somatotrophinomas with loss of alleles on chromosome 11 and with gsp mutations.
Thakker, R. V., Pook, M. A., Wooding, C., Boscaro, M., Scanarini, M., & Clayton, R. N. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116524 · Cited by 148
Somatostatin Analogs Modulate AIP in Somatotroph Adenomas: The Role of the ZAC1 Pathway
Chahal, H., Trivellin, G., Leontiou, C. A., Alband, N., Fowkes, R. C., Tahir, A., Igreja, S., Chapple, J. P., Jordan, S., Lupp, A., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1111 · Cited by 142
Pituitary tumors in childhood: update of diagnosis, treatment and molecular genetics
Keil, M. F., & Stratakis, C. A. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.4.563 · Cited by 139
Teh, B. T. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.8.2621 · Cited by 138
Structure, function and evolution of microbial adenylyl and guanylyl cyclases
Baker, D. A., & Kelly, J. M. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04067.x · Cited by 129
XAP2, a novel hepatitis B virus X-associated protein that inhibits X transactivation
Kuzhandaivelu, N. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.23.4741 · Cited by 123
Patent Ductus Venosus and Dioxin Resistance in Mice Harboring a Hypomorphic Arnt Allele
Walisser, J. A., Bunger, M. K., Glover, E. A., Harstad, E. B., & Bradfield, C. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400784200 · Cited by 121
Chahal, H., Chapple, J. P., Frohman, L. A., Grossman, A. B., & Korbonits, M. (2010) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2010.02.007 · Cited by 118
[The pituitary and hormonal calcium regulation system].
Salzer, G. M. (1971) · PubMed · Cited by 118
Kjellman, M., Roshani, L., Teh, B. T., Kallioniemi, O., Höög, A., Gray, S. G., Farnebo, L., Holst, M., Bäckdahl, M., & Larsson, C. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5506 · Cited by 115
Cazabat, L., Libé, R., Perlemoine, K., René-Corail, F., Burnichon, N., Gimenez‐Roqueplo, A., Pasquier-Fediaevsky, L. D., BERTAGNA, X. Y., Clauser, É., Chanson, P., et al. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0181 · Cited by 114
Clinical and molecular genetics of Carney complex
Rothenbühler, A., & Stratakis, C. A. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.03.003 · Cited by 113
de Oliveira, S. K., Hoffmeister, M., Gambaryan, S. P., Müller‐Esterl, W., Guimarães, J. A., & Smolenski, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610942200 · Cited by 111
Sumanasekera, W. K., Tien, E. S., Turpey, R., Heuvel, J. P. V., & Perdew, G. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211261200 · Cited by 111
AIP is a mitochondrial import mediator that binds to both import receptor Tom20 and preproteins
Yano, M., Terada, K., & Mori, M. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200305051 · Cited by 111
Tanaka, C., Yoshimoto, K., Yamada, S., Nishioka, H., Ii, S., Moritani, M., Yamaoka, T., & Itakura, M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4653 · Cited by 107
Iwata, T., Yamada, S., Mizusawa, N., Golam, H. M., Sano, T., & Yoshimoto, K. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02758.x · Cited by 99
Lin, B. C., Sullivan, R., Lee, Y., Moran, S. M., Glover, E. A., & Bradfield, C. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705471200 · Cited by 97
Xekouki, P., & Stratakis, C. A. (2012) · Endocrine Related Cancer · doi:10.1530/erc-12-0118 · Cited by 97
Naves, L. A., Daly, A., Vanbellinghen, J.-F., Casulari, L. A., Spilioti, C., de Magalhães, A. V., Azevedo, M. F., Giacomini, L., Nascimento, P. P., Nunes, R. O., et al. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0533 · Cited by 95
Self-citationPoncin, J., Abs, R., Velkeniers, B., Bonduelle, M., Abramowicz, M. J., Legros, J., Verloès, A., Meurisse, M., Gaal, L. V., Verellen, C., et al. (1999) · Human Mutation · doi:10.1002/(sici)1098-1004(1999)13:1<54::aid-humu6>3.0.co;2-k · Cited by 94
Self-citationWhen orthologs diverge between human and mouse
Gharib, W. H., & Robinson‐Rechavi, M. (2011) · Briefings in Bioinformatics · doi:10.1093/bib/bbr031 · Cited by 92
[Epidemiology of pituitary adenoma: results of the first Swiss study].
Fontana, E., & Gaillard, R.-C. (2009) · PubMed · Cited by 90
Cañibano, C., Rodríguez-Losada, N., Sáez, C., Tovar, S. A., García-Lavandeira, M., Borrello, M. G., Vidal, A., Costantini, F. D., Japón, M. Á., Diéguez, C., et al. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601636 · Cited by 88
Georgitsi, M., Menis, E. D., Cannavò, S., Mäkinen, M. J., Tuppurainen, K., Pauletto, P., Curtò, L., Weil, R. J., Paschke, R., Zieliński, G., et al. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03266.x · Cited by 82
Self-citationTrivellin, G., Butz, H., Delhove, J. M. K. M., Igreja, S., Chahal, H., Živković, V., McKay, T. R., Patócs, A., Grossman, A. B., & Korbonits, M. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00546.2011 · Cited by 81
Raitila, A., Lehtonen, H. J., Arola, J. T., Heliövaara, E., Ahlsten, M., Georgitsi, M., Jalanko, A., Paetau, A. E., Aaltonen, L. A., & Karhu, A. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100138 · Cited by 81
Self-citationFamilial pituitary adenomas – who should be tested for AIP mutations?
Korbonits, M., Storr, H. L., & Kumar, A. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04445.x · Cited by 80
Sumanasekera, W. K., Tien, E. S., Davis, J. W., Turpey, R., Perdew, G. H., & Heuvel, J. P. V. (2003) · Biochemistry · doi:10.1021/bi0347353 · Cited by 79
Regulation of Survivin Stability by the Aryl Hydrocarbon Receptor-interacting Protein
Kang, B. H., & Altieri, D. C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603175200 · Cited by 79
Villa, C., Lagonigro, M. S., Magri, F., Koziak, M., Jaffrain‐Rea, M., Brauner, R., Bouligand, J., Junier, M., Rocco, F. D., Sainte‐Rose, C., et al. (2011) · Endocrine Related Cancer · doi:10.1530/erc-11-0059 · Cited by 74
Self-citationNord, K. H., Magnusson, L., Isaksson, M., Nilsson, J., Lilljebjörn, H., Domanski, H. A., Kindblom, L., Mandahl, N., & Mertens, F. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013512107 · Cited by 73
Vargiolu, M., Fusco, D., Kurelac, I., Dirnberger, D., Baumeister, R., Morra, I., Melcarne, A., Rimondini, R., Romeo, G., & Bonora, E. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1980 · Cited by 72
Fukuoka, H., Cooper, O. B., Mizutani, J., Tong, Y., Ren, S.-G., Bannykh, S., & Melmed, S. K. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0353 · Cited by 71
The Expression of AIP-Related Molecules in Elucidation of Cellular Pathways in Pituitary Adenomas
Heliövaara, E., Raitila, A., Launonen, V., Paetau, A. E., Arola, J. T., Lehtonen, H. J., Sane, T., Weil, R. J., Kuismin, O., Salmela, P. I., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081131 · Cited by 69
Self-citationSim2 Contributes to Neuroendocrine Hormone Gene Expression in the Anterior Hypothalamus
Goshu, E., Jin, H., Lovejoy, J., Marion, J.-F., Michaud, J. L., & Fan, C. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0372 · Cited by 69
Ramadoss, P., & Perdew, G. H. (2005) · Biochemistry · doi:10.1021/bi050948b · Cited by 68
Regulation of cAMP Responses by the G12/13 Pathway Converges on Adenylyl Cyclase VII
Jiang, L. I., Collins, J. N. R., Davis, R., Fraser, I. D. C., & Sternweis, P. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803281200 · Cited by 66
MacKenzie, S. J., Yarwood, S. J., Peden, A., Bolger, G. B., Vernon, R. G., & Houslay, M. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3549 · Cited by 65
Huizenga, N. A. T. M., de Lange, P., Koper, J. W., Clayton, R. N., Farrell, W. E., van der Lely, A. J., Brinkmann, A. O., de Jong, F. H., & Lamberts, S. W. J. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4648 · Cited by 64
Kjellman, M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.2.730 · Cited by 64
Nukaya, M., Lin, B. C., Glover, E. A., Moran, S. M., Kennedy, G. D., & Bradfield, C. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.132043 · Cited by 62
de Herder, W. W. (2008) · Pituitary · doi:10.1007/s11102-008-0138-y · Cited by 62
Regulation of epidermal growth factor receptor trafficking by lysine deacetylase HDAC6
Lissanu Deribe, Y., Wild, P., Chandrashaker, A., Curak, J., Schmidt, M. H. H., Kalaidzidis, Y., Milutinovic, N., Kratchmarova, I., Buerkle, L., Fetchko, M. J., et al. (2009) · Science Signaling · doi:10.1126/scisignal.2000576 · Cited by 60
Kashuba, E., Gradin, K., Isaguliants, M., Székely, L., Poellinger, L., Klein, G., & Kazlauskas, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509036200 · Cited by 60
Georgitsi, M., Karhu, A., Winqvist, R., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603573 · Cited by 59
Self-citationCheon, H. J., Woo, Y.-S., Lee, J. Y., Kim, H. S., Kim, H. J., Cho, S., Won, N. H., & Sohn, J. (2007) · Experimental & Molecular Medicine · doi:10.1038/emm.2007.58 · Cited by 59
Kazlauskas, A., Poellinger, L., & Pongratz, I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200053200 · Cited by 59
Somatic MEN1 gene mutation does not contribute significantly to sporadic pituitary tumorigenesis
Poncin, J., Stevenaert, A., & Beckers, A. M. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1400573 · Cited by 59
Self-citationPollenz, R. S., & Dougherty, E. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506619200 · Cited by 56
Pollenz, R. S., & Buggy, C. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.08.014 · Cited by 56
Horváth, É., & Kovács, K. (2006) · Neuroendocrinology · doi:10.1159/000095524 · Cited by 55
Hollingshead, B. D., Petrulis, J. R., & Perdew, G. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407840200 · Cited by 55
Vandeva, S., Vasilev, V., Vroonen, L., Naves, L. A., Jaffrain‐Rea, M., Daly, A., Zacharieva, S., & Beckers, A. M. (2010) · Annales d Endocrinologie · doi:10.1016/j.ando.2010.08.005 · Cited by 55
Self-citationAnalysis of Ah Receptor-ARNT and Ah Receptor-ARNT2 Complexes In Vitro and in Cell Culture
Dougherty, E. J., & Pollenz, R. S. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm300 · Cited by 55
Raitila, A., Georgitsi, M., Karhu, A., Tuppurainen, K., Mäkinen, M. J., Birkenkamp‐Demtröder, K., Salmenkivi, K., Orntoft, T. F., Arola, J. T., Launonen, V., et al. (2007) · Endocrine Related Cancer · doi:10.1677/erc-07-0025 · Cited by 55
Self-citationDifferent transcriptional properties of mSim‐1 and mSim‐2
Moffett, P., & Pelletier, J. (2000) · FEBS Letters · doi:10.1016/s0014-5793(99)01750-0 · Cited by 53
Jennings, J., Georgitsi, M., Holdaway, I. M., Daly, A., Tichomirowa, M. A., Beckers, A. M., Aaltonen, L. A., Karhu, A., & Cameron, F. J. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0406 · Cited by 53
Self-citationTruncated somatostatin receptors as new players in somatostatin–cortistatin pathophysiology
Córdoba‐Chacón, J., Gahete, M. D., Durán‐Prado, M., Luque, R. M., & Castano, J. P. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.05985.x · Cited by 52
Mutations of the Gene for the Aryl Hydrocarbon Receptor-Interacting Protein in Pituitary Adenomas
Cazabat, L., Guillaud-Bataille, M., Bertherat, J. Y., & Raffin‐Sanson, M. (2009) · Hormone Research in Paediatrics · doi:10.1159/000197869 · Cited by 52
Boikos, S. A., & Stratakis, C. A. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm019 · Cited by 50
Kashuba, E., Kashuba, V. I., Tamm, K. P., Klein, G., & Székely, L. (2000) · Oncogene · doi:10.1038/sj.onc.1203501 · Cited by 50
Pesatori, A. C., Baccarelli, A., Consonni, D., Lania, A. G., Beck‐Peccoz, P., Bertazzi, P. A., & Spada, A. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0593 · Cited by 49
Lin, B. C., Nguyen, L. P., Walisser, J. A., & Bradfield, C. A. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.047068 · Cited by 48
Anterior pituitary adenomas: inherited syndromes, novel genes and molecular pathways
Xekouki, P., Azevedo, M. F., & Stratakis, C. A. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.10.47 · Cited by 48
Pathogenesis of Pituitary Tumors
Yu, R., & Melmed, S. K. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)82009-6 · Cited by 45
Carney complex: Clinical and genetic 2010 update
Vezzosi, D., Vignaux, O., Dupin, N., & Bertherat, J. Y. (2010) · Annales d Endocrinologie · doi:10.1016/j.ando.2010.08.002 · Cited by 44
Berezin, M., & Karasik, A. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02666.x · Cited by 44
The Networking of Chaperones by Co-chaperones
Edkins, A. L., & Blatch, G. L. (2014) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-319-11731-7 · Cited by 43
Fritz, W. A., Lin, T., & Peterson, R. E. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn069 · Cited by 43
A meiotic recombination in a new isolated familial somatotropinoma kindred
Luccio-Camelo, D., Une, K. N., Ferreira, R., Khoo, S., Nickolov, R. Z., Bronstein, M., Vaisman, M., Teh, B. T., La, F., Mendonca, B. B., et al. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500643 · Cited by 43
The MEN1 Gene and Pituitary Tumours
Agarwal, S. K., Ozawa, A., Mateo, C. M., & Marx, S. J. (2009) · Hormone Research in Paediatrics · doi:10.1159/000192450 · Cited by 42
Personnier, C., Cazabat, L., Bertherat, J. Y., Gaillard, S., Souberbielle, J., Habrand, J. L., Dufour, C., Clauser, É., Sainte‐Rose, C., & Polak, M. (2011) · Hormone Research in Paediatrics · doi:10.1159/000327831 · Cited by 41
Clerget-Froidevaux, M.-S., Berg, P., Seugnet, I., Decherf, S., Becker, N., Sachs, L. M., Bilesimo, P., Nygård, M., Pongratz, I., & DEMENEIX, B. A. (2006) · EMBO Reports · doi:10.1038/sj.embor.7400778 · Cited by 40
Toledo, R. A., Mendonca, B. B., Fragoso, M. C. B. V., Soares, I. C., Almeida, M. Q., de Moraes, M. B., Lourenço, D. M., Alves, V. A. F., Bronstein, M. D., & Toledo, S. P. A. (2010) · Clinics · doi:10.1590/s1807-59322010000400010 · Cited by 39
XAP2 inhibits glucocorticoid receptor activity in mammalian cells
Laenger, A., Lang‐Rollin, I., Kozany, C., Zschocke, J., Zimmermann, N., Rüegg, J., Holsboer, F., Hausch, F., & Rein, T. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.03.072 · Cited by 39
PRKAR1A and the evolution of pituitary tumors
Kirschner, L. S. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.04.027 · Cited by 39
G‐protein signalling negatively regulates the stability of aryl hydrocarbon receptor
Nakata, A., Urano, D., Fujii‐Kuriyama, Y., Mizuno, N., Tago, K., & Itoh, H. (2009) · EMBO Reports · doi:10.1038/embor.2009.35 · Cited by 38
Should the skeleton of "the Irish giant" be buried at sea?
Doyal, L., & Muinzer, T. L. (2011) · BMJ · doi:10.1136/bmj.d7597 · Cited by 36
Huizenga, N. A. T. M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.3.917 · Cited by 33
Frohman, L. A., & Eguchi, K. (2004) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2004.03.021 · Cited by 31
Peng, L. H., Mayhew, C. N., Schnekenburger, M., Knudsen, E. S., & Puga, A. (2008) · Toxicology · doi:10.1016/j.tox.2008.01.002 · Cited by 30
Khoo, S. K., Pendek, R., Nickolov, R. Z., Luccio-Camelo, D., Newton, T. L., Massie, A. B., Petillo, D., Menon, J., Cameron, D. P., Teh, B. T., et al. (2009) · Endocrine Related Cancer · doi:10.1677/erc-08-0287 · Cited by 30
Pereira‐Lima, J. F. S., Marroni, C. P., Pizarro, C. B., Barbosa-Coutinho, L. M., Ferreira, N. P., & Oliveira, M. C. (2004) · Neuroendocrinology · doi:10.1159/000077269 · Cited by 29
Guaraldi, F., Corazzini, V., Gallia, G. L., Grottoli, S., Stals, K. L., Dalantaeva, N. S., Frohman, L. A., Korbonits, M., & Salvatori, R. (2012) · Pituitary · doi:10.1007/s11102-012-0391-y · Cited by 22
G-Protein and Signalling in Pituitary Tumours
Lania, A. G., & Spada, A. (2009) · Hormone Research in Paediatrics · doi:10.1159/000192446 · Cited by 20
Familial Isolated Pituitary Adenomas: From Genetics to Therapy
Guaraldi, F., & Salvatori, R. (2011) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2010.00254.x · Cited by 19
Pitt, J. A., Buckalew, A. R., House, D. E., & Abbott, B. D. (2000) · Toxicology · doi:10.1016/s0300-483x(00)00257-2 · Cited by 16
Isolated familial somatotropinomas: clinical and genetic considerations.
Frohman, L. A. (2003) · PubMed · Cited by 7
Functions of the Hsp90-Binding FKBP Immunophilins
Cox, M. B., & Smith, D. F. (2007) · Springer eBooks · doi:10.1007/978-0-387-49310-7_2 · Cited by 7
Familial Cushing's disease with severe weight loss occurring in late childhood
Cameron, F. J., & WARNE, G. (1997) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.1997.tb00996.x · Cited by 5
Familial pituitary adenomas with a heterogeneous functional pattern: Clinical and genetic features
Raverot, G., Arnous, W., Calender, A., Trouillas, J., Sassolas, G., Bournaud, C., Pugeat, M., & Borson‐Chazot, F. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03350819 · Cited by 5
Fajardo, C., Daly, A., Riesgo-Suárez, P., Gómez-Vela, J., Tichomirowa, M. A., Cámara-Gómez, R., & Beckers, A. M. (2009) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(09)72456-8
Self-citation
Cited by
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Gigantism and Acromegaly Due to Xq26 Microduplications and GPR101 Mutation
Trivellin, G., Daly, A. F., Faucz, F. R., Yuan, B., Rostomyan, L., Larco, D. O., Schernthaner-Reiter, M. H., Szarek, E., Leal, L. F., Caberg, J.-H., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408028 · Cited by 355
Self-citationEndocrine Disrupting Chemicals: Effects on Endocrine Glands
Lauretta, R., Sansone, A., Sansone, M., Romanelli, F., & Appetecchia, M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00178 · Cited by 340
Aggressive pituitary adenomas—diagnosis and emerging treatments
Di Ieva, A., Rotondo, F., Syro, L. V., Cusimano, M. D., & Kovacs, K. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.64 · Cited by 318
Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas
Ntali, G., & Wass, J. A. (2018) · Pituitary · doi:10.1007/s11102-018-0869-3 · Cited by 285
Metadata
- Authors
- Beckers, A., Aaltonen, L. A., Daly, A. F., & Karhu, A.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2013-01-31
- Volume
- 34
- Issue
- 2
- Pages
- 239-277
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2143755574
- Cited by
- 360
- References
- 176
- FWCI
- 25.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.